Table 3 Post-operative outcomes of HCC patients 1 month after RFA
NT-RFA (n = 46) | C-RFA (n = 84) | |||||
|---|---|---|---|---|---|---|
Pre-RFA | Post-RFA | P value | Pre-RFA | Post-RFA | P value | |
ALT, IU/L | 30.4 (21.1–46.3) | 34.8 (22.8–69.4) | 0.100 | 31.7 (23.8–46.5) | 34.0 (25.0–53.9) | 0.941 |
TBIL, μmol/L | 18.8 (14.6–22.7) | 18.4 (15.5–25.5) | 0.419 | 17.3 (12.6–21.8) | 21.1 (14.1–29.6) | 0.233 |
ALP, IU/L | 101.0 (81.8–118.3) | 100.0 (86.8–138.8) | 0.384 | 90.0 (77.0–112.0) | 110.0 (87.0–145.0) | < 0.001 |
TBA, μmol/L | 5.7 (2.5–11.4) | 8.1 (2.9–20.0) | 0.233 | 7.6 (2.9–16.2) | 5.6 (3.1–13.6) | 0.304 |
AST, IU/L | 31.9 (27.0–44.6) | 37.9 (30.8–50.7) | < 0.001 | 34.9 (28.4–45.2) | 37.7 (31.2–50.0) | 0.363 |
Alb, g/L | 44.7 (40.1–46.7) | 43.3 (37.9–47.2) | 0.149 | 44.8 (40.1–47.4) | 42.5 (30.7–45.8) | 0.045 |
PLT, 10^9/L | 122.5 (91.8–163.3) | 104.5 (74.0–138.0) | < 0.001 | 118.5 (78.5–147.5) | 103.0 (77.0–150.5) | 0.112 |
AFP, ng/mL | 22.1 (4.3–224.6) | 5.0 (3.0–13.7) | < 0.001 | 13.0 (3.3–105.8) | 4.9 (2.8–15.2) | < 0.001 |